MIF and gestational diabetes: Another MØ secretory signal, a pro-inflammatory cytokine known as MØ migration inhibitory factor (MIF) which stimulates TH1 cells, induces IL-17 release, and increases TLR-4 expression on MØ is used for GDM prediction (Figure 2C) (Yilmaz et al., 2012).